Wang X, Li N, Xie Y, Zhu L, Li J, Gu F
Front Surg. 2022; 9:968077.
PMID: 36211262
PMC: 9540468.
DOI: 10.3389/fsurg.2022.968077.
Beatty A, Rubin A, Wada H, Heidinger B, Hood W, Schwartz T
Proc Biol Sci. 2022; 289(1969):20212278.
PMID: 35193406
PMC: 8864354.
DOI: 10.1098/rspb.2021.2278.
Nadella K, Berthon A, Almeida M, Levy I, Faucz F, Stratakis C
Endocrine. 2021; 72(3):823-834.
PMID: 33420948
DOI: 10.1007/s12020-020-02583-z.
Baral K, Rotwein P
PLoS One. 2019; 14(6):e0219155.
PMID: 31251794
PMC: 6599137.
DOI: 10.1371/journal.pone.0219155.
Garla V, Sonani H, Palabindala V, Gomez-Sanchez C, Subauste J, Lien L
Front Endocrinol (Lausanne). 2019; 10:316.
PMID: 31156561
PMC: 6529841.
DOI: 10.3389/fendo.2019.00316.
The insulin-like growth factor 2 gene and locus in nonmammalian vertebrates: Organizational simplicity with duplication but limited divergence in fish.
Rotwein P
J Biol Chem. 2018; 293(41):15912-15932.
PMID: 30154247
PMC: 6187628.
DOI: 10.1074/jbc.RA118.004861.
Atlas of tissue- and developmental stage specific gene expression for the bovine insulin-like growth factor (IGF) system.
Ghanipoor-Samami M, Javadmanesh A, Burns B, Thomsen D, Nattrass G, Estrella C
PLoS One. 2018; 13(7):e0200466.
PMID: 30001361
PMC: 6042742.
DOI: 10.1371/journal.pone.0200466.
Similarity and variation in the insulin-like growth factor 2 - H19 locus in primates.
Rotwein P
Physiol Genomics. 2018; 50(6):425-439.
PMID: 29602297
PMC: 6032289.
DOI: 10.1152/physiolgenomics.00030.2018.
The complex genetics of human insulin-like growth factor 2 are not reflected in public databases.
Rotwein P
J Biol Chem. 2018; 293(12):4324-4333.
PMID: 29414792
PMC: 5868277.
DOI: 10.1074/jbc.RA117.001573.
Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.
Enguita-German M, Fortes P
World J Hepatol. 2014; 6(10):716-37.
PMID: 25349643
PMC: 4209417.
DOI: 10.4254/wjh.v6.i10.716.
Inducing human parthenogenetic embryonic stem cells into islet‑like clusters.
Li J, He J, Lin G, Lu G
Mol Med Rep. 2014; 10(6):2882-90.
PMID: 25241773
PMC: 4227434.
DOI: 10.3892/mmr.2014.2588.
The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging.
Oberbauer A
Front Endocrinol (Lausanne). 2013; 4:39.
PMID: 23533068
PMC: 3607797.
DOI: 10.3389/fendo.2013.00039.
Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment.
Kimura T, Kuwata T, Ashimine S, Yamazaki M, Yamauchi C, Nagai K
Clin Cancer Res. 2009; 16(1):121-9.
PMID: 20028742
PMC: 2802676.
DOI: 10.1158/1078-0432.CCR-09-0982.
A comparative structural bioinformatics analysis of the insulin receptor family ectodomain based on phylogenetic information.
Renteria M, Gandhi N, Vinuesa P, Helmerhorst E, Mancera R
PLoS One. 2008; 3(11):e3667.
PMID: 18989367
PMC: 2577065.
DOI: 10.1371/journal.pone.0003667.
Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I.
Gauguin L, Delaine C, Alvino C, McNeil K, Wallace J, Forbes B
J Biol Chem. 2008; 283(30):20821-9.
PMID: 18502759
PMC: 3258947.
DOI: 10.1074/jbc.M802620200.
IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.
Zumkeller W, Mahmood A, Dellow R, Schofield P
Clin Mol Pathol. 1995; 48(6):M333-41.
PMID: 16696034
PMC: 408001.
DOI: 10.1136/mp.48.6.m333.
A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview.
Chen J, Ferec C, Cooper D
Hum Genet. 2006; 120(1):1-21.
PMID: 16645853
DOI: 10.1007/s00439-006-0180-7.
Translation initiation on the insulin-like growth factor II leader 1 is developmentally regulated.
Teerink H, Kasperaitis M, de Moor C, VOORMA H, Thomas A
Biochem J. 1994; 303 ( Pt 2):547-53.
PMID: 7980416
PMC: 1137362.
DOI: 10.1042/bj3030547.
Proteins binding to the leader of the 6.0 kb mRNA of human insulin-like growth factor 2 influence translation.
de Moor C, Jansen M, Bonte E, Thomas A, Sussenbach J, VAN DEN BRANDE J
Biochem J. 1995; 307 ( Pt 1):225-31.
PMID: 7717979
PMC: 1136766.
DOI: 10.1042/bj3070225.
Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?.
Zapf J, Futo E, Peter M, FROESCH E
J Clin Invest. 1992; 90(6):2574-84.
PMID: 1281841
PMC: 443417.
DOI: 10.1172/JCI116152.